Anthocyanins attenuate neuroinflammation through the suppression of MLK3 activation in a mouse model of perioperative neurocognitive disorders

Brain Res. 2020 Jan 1:1726:146504. doi: 10.1016/j.brainres.2019.146504. Epub 2019 Oct 22.

Abstract

Perioperative neurocognitive disorder (PND) is a common complication that lacks effective prevention and treatment measures. Neuroinflammation is considered to be one of the important mechanisms of PND. In this study, we investigated the effect and mechanism of anthocyanins (ANT), a natural plant ingredient, on postoperative cognition and neuroinflammation. Mice were subjected to laparotomy and treated with ANT (50-100 mg/kg, orally) 4 weeks before surgery and then once per day for 7 days after surgery. Morris water maze and fear conditioning tests were used to evaluate learning and memory function. Western blotting, RT-PCR and immunofluorescence were used to test the neuroprotective effects and mechanism of ANT. The results showed that ANT improved learning and memory in mice after surgery. ANT also inhibited MLK3 activation and its downstream JNK and p38 MAPK signaling cascades. Moreover, the inhibitor of MLK3 could mimic the effects of ANT. In addition, treatment with ANT significantly reduced neuroinflammation and microglia activation. In conclusion, MLK3 represents a novel target in surgery-induced neuroinflammation and cognitive dysfunction. ANT could inhibit the activation of MLK3 and be a promising agent for the prevention and treatment of PND.

Keywords: Anthocyanins; JNK; MLK3; Perioperative neurocognitive disorder; p38 MAPK.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anthocyanins / administration & dosage*
  • Disease Models, Animal
  • Encephalitis / metabolism*
  • Encephalitis / prevention & control*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Learning / drug effects
  • MAP Kinase Kinase Kinases / metabolism*
  • Male
  • Memory / drug effects
  • Mice
  • Mitogen-Activated Protein Kinase Kinase Kinase 11
  • Neurocognitive Disorders / metabolism*
  • Neurocognitive Disorders / prevention & control*
  • Neuroprotective Agents / administration & dosage*
  • Perioperative Period
  • Signal Transduction / drug effects

Substances

  • Anthocyanins
  • Neuroprotective Agents
  • MAP Kinase Kinase Kinases